These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 17524745)

  • 21. Rate versus rhythm control in the management of patients with atrial fibrillation.
    Pelargonio G; Prystowsky EN
    Nat Clin Pract Cardiovasc Med; 2005 Oct; 2(10):514-21. PubMed ID: 16186849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cardiac arrhythmias in the elderly].
    Guize L; Piot O; Lavergne T; Le Heuzey JY
    Bull Acad Natl Med; 2006; 190(4-5):827-41; discussion 873-6. PubMed ID: 17195610
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pro: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Why warfarin should really be the drug of choice for stroke prevention in elderly patients with atrial fibrillation.
    Mant JW
    Thromb Haemost; 2008 Jul; 100(1):14-5. PubMed ID: 18612531
    [No Abstract]   [Full Text] [Related]  

  • 24. [Anticoagulant treatment of patients with atrial fibrillations: dependent on age and other risk factors for thromboembolism].
    Vink R; van den Brink RB; Levi M
    Ned Tijdschr Geneeskd; 2002 Nov; 146(48):2285-9. PubMed ID: 12497755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multicenter randomized study of anticoagulation guided by remote rhythm monitoring in patients with implantable cardioverter-defibrillator and CRT-D devices: Rationale, design, and clinical characteristics of the initially enrolled cohort The IMPACT study.
    Ip J; Waldo AL; Lip GY; Rothwell PM; Martin DT; Bersohn MM; Choucair WK; Akar JG; Wathen MS; Rohani P; Halperin JL;
    Am Heart J; 2009 Sep; 158(3):364-370.e1. PubMed ID: 19699858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overview of management of atrial fibrillation in symptomatic elderly patients: pharmacologic therapy versus AV node ablation.
    Bradley DJ; Shen WK
    Clin Pharmacol Ther; 2007 Feb; 81(2):284-7. PubMed ID: 17259952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of atrial fibrillation and atrial flutter: Part II.
    Aronow WS
    Cardiol Rev; 2008; 16(5):230-9. PubMed ID: 18708824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atrial fibrillation in the elderly.
    Wetzel U; Hindricks G; Piorkowski C
    Minerva Med; 2009 Apr; 100(2):145-50. PubMed ID: 19390500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atrial fibrillation.
    Lip GY; Tse HF; Lane DA
    Lancet; 2012 Feb; 379(9816):648-61. PubMed ID: 22166900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness of genotype-guided warfarin therapy for anticoagulation in elderly patients with atrial fibrillation.
    Leey JA; McCabe S; Koch JA; Miles TP
    Am J Geriatr Pharmacother; 2009 Aug; 7(4):197-203. PubMed ID: 19766951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Should hemodialysis patients with atrial fibrillation undergo systemic anticoagulation? A cost-utility analysis.
    Quinn RR; Naimark DM; Oliver MJ; Bayoumi AM
    Am J Kidney Dis; 2007 Sep; 50(3):421-32. PubMed ID: 17720521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A cautionary note on data sources for evidence-based clinical decisions: warfarin and stroke prevention.
    Thomson R; Eccles M; Wood R; Chinn DJ
    Med Decis Making; 2007; 27(4):438-47. PubMed ID: 17641140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidenced-based pharmacotherapy for rate control in atrial fibrillation.
    Greenberg H
    Crit Care Nurs Q; 2013; 36(2):237-43. PubMed ID: 23470710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.
    Hylek EM
    Thromb Haemost; 2008 Jul; 100(1):16-7. PubMed ID: 18612532
    [No Abstract]   [Full Text] [Related]  

  • 35. The need for new oral anticoagulants in clinical practice.
    Hylek EM
    J Cardiovasc Med (Hagerstown); 2009 Aug; 10(8):605-9. PubMed ID: 19571764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stroke prevention in atrial fibrillation--pharmacologic strategies.
    Tiyyagura SR; Goldbarg SH; Mehta D
    Indian Heart J; 2007; 59(4):311-5. PubMed ID: 19126935
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anticoagulation therapy in older adults newly diagnosed with atrial fibrillation.
    Walling J; Spain M; Edlund BJ
    J Gerontol Nurs; 2011 Oct; 37(10):9-13. PubMed ID: 21919422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Anticoagulation in atrial fibrillation].
    Binggeli C; Brunckhorst CB
    Herz; 2008 Feb; 33(1):13-9. PubMed ID: 18273573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardioembolic stroke: call for a multidisciplinary approach.
    Babarro EG; Rego AR; González-Juanatey JR
    Cerebrovasc Dis; 2009; 27 Suppl 1():82-7. PubMed ID: 19342836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Atrial fibrillation in elderly patients].
    Massoure PL; Sacher F; Derval N; Hocini M; Jais P; Haissaguerre M
    Rev Prat; 2009 Dec; 59(10):1365-9. PubMed ID: 20058755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.